1887

oa Modern Medicine - ASA and Anturan: their effects on the clinical complications of atherosclerosis

Volume 6, Issue 7
  • ISSN : 0259-9333

 

Abstract

Results have been reported recently of several large-scale, randomized, doable-blind trials of ASA and sulphinpyrazone in patients with recurring transient attacks of cerebral ischaemia (TLA) and in postmyocardial infarction patients.

Loading full text...

Full text loading...

Loading

Article metrics loading...

/content/jomm/6/7/AJA02599333_820
1981-07-01
2017-03-30

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error